AN ACT relating to undesignated glucagon.

Create new sections of KRS Chapter 217 to define terms; permit health care practitioners to prescribe and dispense undesignated glucagon in the name of a school; permit authorized entities to receive, possess, and administer undesignated glucagon to a student during diabetic medical emergencies; permit schools to stock undesignated glucagon; provide for immunity from civil liability for any personal injury resulting from good-faith actions to use undesignated glucagon to treat diabetic medical emergencies; require the Cabinet for Health and Family Services to consult the American Diabetes Association when promulgating administrative regulations related to the administration of undesignated glucagon in schools.

Introduced: January 8, 2026

Last action: January 15, 2026

To Health Services (H)

Read the full text Kentucky Legislature LegiScan

AI-generated — always verify with primary sources

Plain-language summary

Beta

This bill would allow schools to keep glucagon on hand without it being prescribed to a specific student, so trained staff can use it to treat diabetic emergencies when they occur. Health care providers could prescribe glucagon directly to a school, and people who act in good faith to help a student in a diabetic crisis would be protected from lawsuits. The state health cabinet would also be required to consult the American Diabetes Association when writing rules about how schools use glucagon. Who it may affect: students with diabetes, their parents, school staff, and school administrators.

Open official bill text (PDF)·Report a problem with the summary